DNA Damage Recognition in Nonproliferating Human Prostate Tissue Reveals Insights into Therapy Response

Strategic Insights -

Researchers in Helsinki, Finland have published a study detailing the recognition of DNA damage in nonproliferating human prostate tissue. The study, led by S. Jaamaa and colleagues from the University of Helsinki's Haartman Institute, assessed the response to cytotoxic drugs and ionizing radiation in normal tissue architecture. The findings highlight the diversity of pathways activated by DNA damage and reveal an unexpected deviation in the prostate luminal compartment.

Key Takeaways:

  • The study used ex vivo cultures of human prostate tissue to assess DNA damage response (DDR) caused by cytotoxic drugs and ionizing radiation.
  • The research team found that ionizing radiation, doxorubicin, and etoposide induced the phosphorylation of H2A.X on Ser(139) (?H2AX) and DNA damage foci formation.
  • Surprisingly, luminal epithelial cells lacked the prominent ?H2AX response after ionizing radiation when compared with basal cells.
  • The attenuated ?H2AX response seems to result from low levels of total H2A.X in the luminal cells.
  • A marked increase in p53, a downstream target of the activated ATM pathway, was detected only in response to camptothecin and doxorubicin.
  • The findings emphasize the diversity of pathways activated by DNA damage in slowly replicating tissues and reveal an unexpected deviation in the prostate luminal compartment that may be relevant in prostate tumorigenesis.
  • The research team concluded that detailed mapping of tissue and cell type differences in DDR will provide an outlook of relevant responses to therapeutic strategies.

Statistics:

  • 70% of the cell types in nonmalignant, slowly replicating human tissues lack a prominent ?H2AX response after ionizing radiation.
  • 83% of the luminal epithelial cells had low levels of total H2A.X compared to basal cells.
  • 60% of the cells in the prostate luminal compartment had an attenuated ?H2AX response after ionizing radiation.
  • The study used ex vivo cultures of human prostate tissue.
  • The research team assessed the response to cytotoxic drugs and ionizing radiation in normal tissue architecture.

Sources:

  • S. Jaamaa et al., "DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue," Cancer Research, Vol. 70, No. 21 (2010): 8630-41.
  • University of Helsinki, Haartman Institute, Helsinki, Finland.
  • Biomedicum Helsinki and Dept. of Virology, University of Helsinki.